Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis

Area of Science:

• Molecular Biology
• Cardiovascular Research
• RNA Biology

Background:

• Circular RNAs (circRNAs) are a novel class of non-coding RNAs with significant clinical potential.
• Their unique structure and regulatory roles are areas of intense scientific interest.
• Understanding circRNA function is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the function of circFASTKD1 in vascular endothelial cells.
• To elucidate the molecular mechanism underlying circFASTKD1's role in angiogenesis.
• To evaluate the therapeutic potential of circFASTKD1 modulation in myocardial infarction.

Main Methods:

• Investigated circRNA-miRNA-mRNA interactions using molecular biology techniques.
• Assessed the effects of circFASTKD1 expression on vascular endothelial cell functions (viability, migration, tube formation).
• Evaluated the impact of circFASTKD1 downregulation on cardiac function and repair in a mouse model of myocardial infarction.

Main Results:

• CircFASTKD1 directly binds to miR-106a, inhibiting Large Tumor Suppressor Kinases 1 and 2 (LTKS1/2) and suppressing the Yes-Associated Protein (YAP) signaling pathway.
• Ectopic expression of circFASTKD1 reduced vascular endothelial cell functions, while its downregulation promoted angiogenesis under normal and hypoxic conditions.
• Downregulation of circFASTKD1 improved cardiac function and repair post-myocardial infarction in mice.

Conclusions:

• CircFASTKD1 acts as a potent inhibitor of angiogenesis, particularly relevant in the context of myocardial infarction.
• Silencing circFASTKD1 demonstrates therapeutic potential by stimulating angiogenesis, offering a novel approach for hypoxia-related conditions.
• Targeting circFASTKD1 presents a promising strategy for enhancing cardiac repair and treating ischemic heart diseases.